LeadStory

CNBC

First FDA-approved glucose monitor for weight loss

CNBC · Just In
CNBC
CNBC
Just In

Signos CEO Sharam Fouladgar-Mercer joins 'Fast Money' to talk first FDA-approved glucose monitor for weight loss.

Breakdown
  • Cygnos receives FDA approval for its glucose monitoring system for weight loss. 6s
  • The wearable device provides real-time metabolic data to users via a smartphone app. 1m 13s
  • The system costs $129 per month and is FSA, HSA eligible, with insurer reimbursement being explored. 1m 48s
  • Cygnos is positioned as a complementary solution to GLP-1 drugs and aims to be accessible for a broad range of users. 2m 5s
  • The device integrates with other smart health devices and uses AI to predict metabolic outcomes. 4m 4s
Health